Difference between revisions of "Team:SYSU-MEDICINE"

Line 589: Line 589:
 
         </div>
 
         </div>
 
         <div class="my-icon" id="icon-2">
 
         <div class="my-icon" id="icon-2">
−
             <img src="https://static.igem.org/mediawiki/2016/7/77/T--SYSU-MEDICINE--home-Button2.png">
+
             <img src="https://static.igem.org/mediawiki/2016/0/0e/T--SYSU-MEDICINE--home-Button4.png">
 
             <div class="my-card" id="card-2">
 
             <div class="my-card" id="card-2">
−
                 <img src="https://static.igem.org/mediawiki/2016/8/82/T--SYSU-MEDICINE--home-Card2.png">
+
                 <img src="https://static.igem.org/mediawiki/2016/b/b9/T--SYSU-MEDICINE--home-Card4.png">
 
             </div>
 
             </div>
 
         </div>
 
         </div>
Line 601: Line 601:
 
         </div>
 
         </div>
 
         <div class="my-icon" id="icon-4">
 
         <div class="my-icon" id="icon-4">
−
             <img src="https://static.igem.org/mediawiki/2016/0/0e/T--SYSU-MEDICINE--home-Button4.png">
+
             <img src="https://static.igem.org/mediawiki/2016/7/77/T--SYSU-MEDICINE--home-Button2.png">
 
             <div class="my-card" id="card-4">
 
             <div class="my-card" id="card-4">
−
                 <img src="https://static.igem.org/mediawiki/2016/b/b9/T--SYSU-MEDICINE--home-Card4.png">
+
                 <img src="https://static.igem.org/mediawiki/2016/8/82/T--SYSU-MEDICINE--home-Card2.png">
 
             </div>
 
             </div>
 
         </div>
 
         </div>

Revision as of 17:41, 18 October 2016

MSCavalry

-----MSCs of
Next Generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of Next Generation is coming. SYSU-MEDICINE decides to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.